Akers To Raise $2 Million With Private Placement

Akers Biosciences (NASDAQ:AKER) plans to raise close to $2 million through a private placement with Joseph Gunnar & Co., LLC.

As quoted in the press release:

Akers Bio will use the proceeds from the transaction as growth capital and for general corporate purposes.

Akers Bio will issue 1,448,400 shares at a price of $1.40 per share, resulting in gross proceeds to the Company of $2,027,760, before fees and expenses. In addition, the Company will issue 724,200 warrants with a strike price of $1.96 per share and a five-year term.

Joseph Gunnar & Co., LLC acted as sole placement agent for the transaction.

The securities sold in the transaction have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from such registration requirements.

This press release has been issued pursuant to Rule 135c under the Securities Act and does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state.

About Akers Biosciences, Inc.

Akers Bio develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company’s state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical product distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics.

Additional information on the Company and its products can be found at www.akersbio.com. Follow us on Twitter @AkersBio.

Click here to read the full press release.

Get the Latest Biotech Investing Stock Information

Get the latest information about companies associated with Biotech Investing delivered directly to your inbox.

Biotech

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time.

Comments

Leave a Reply